Pasithea Therapeutics Stock News

(RTTNews) - The following are some of the stocks making big moves in Wednesday''s pre-market trading (as of 07.05 A.M. ET). In the Green Ocuphire Pharma, Inc. (OCUP) is up over 50% at $5.23 Pasithea Therapeutics Corp. (KTTA) is up over 40% at $7.86 Engine Gaming and Media, Inc. (GAME) is up over 33% at $4.26 BIOLASE, Inc. (BIOL) is up over 29%

The stock price of Pasithea Therapeutics Corp (NASDAQ: KTTA) increased by over 25% pre-market today. This is why it happened.

FinancialBuzz.coms latest The Buzz Show: Featuring Our Corporate News Recap on Pasithea Therapeutics Corp. Surges Upon SPRAVATO Approval Pasithea Therapeutics Corp. (NASDAQ: KTTA) surged over 196% in premarket trading after the company was approved to provide its esketamine nasal spray for treatment-resistant depression in adults. Pasithea Clinics is one of only three accredited clinics in The post The Buzz Show: Pasithea Therapeutics Corp. (NASDAQ: KTTA) Surges Upon SPRAVATO Approval first appeared on Financial Buzz .

    Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.   – Pasithea Clinics is one of only three accredited clinics in the U.K. approved to offer esketamine nasal spray (SPRAVATO®) for treatment of mental health disorders –   Miami Beach, FL -- November 23, 2021 -- InvestorsHub NewsWire -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) ("Pasithea" or the "Company"), a novel biotechno...

Shares of penny stock KTTA are on the move and here's what's going on. The post Hot Penny Stocks Today: Why Is KTTA Stock Moving?

The stock price of Pasithea Therapeutics Corp (NASDAQ: KTTA) increased by over 135% pre-market today. This is why it happened.

Pasithea Therapeutics (NSDQ:KTTA) announced that it commenced clinical operations with its in-home intravenous ketamine therapy. Miami Beach, Florida-based Pasitheas wholly-owned subsidiary, Pasithea Clinics, offers in-home IV ketamine therapy to patients suffering from treatment-resistant mental health issues. The company will offer the treatment initially in New York City, Los Angeles, San Diego and San Francisco, with [] The post Pasithea launches in-home ketamine infusion platform in U.S. appeared first on Drug Delivery Business .

    Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy in Major U.S. Cities, Expanding its International Footprint   -- Pasithea Clinics to offer ketamine infusion therapy for the treatment of mental health disorders -- -- First mobile clinics launch in New York City, Los Angeles, San Diego, and San Francisco, with expansion to additional U.S. cities in coming months -- -- Treatments conducted by board-certified medical professionals --  ...

Pasithea Clinics partners with ZEN Healthcare – a network of health clinics in Central London – to offer ketamine infusion therapy for the treatment of mental health disorders Ketamine in sub-anes

Pasithea Therapeutics ( KTTA , Financial) ( KTTAW , Financial) caught my eye recently as an emerging biotech player with a different approach to business. On first impression, the company may seem lik

Photo by CDC on Unsplash Pasithea Therapeutics ( NASDAQ: KTTA), a Florida-based biotechnology company, has teamed with life sciences company Evotec SE (OTCMKTS: EVTCY) as its research partner to help

Pasithea Therapeutics Corp (NASDAQ: KTTA) has initiated a new chemical entity development program and named Evotec SE (OTC: EVOTF) its research partner. No deal terms were disclosed.